Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Multicenter, Parallel, Randomized, Double‐Blind, Placebo‐Controlled Trial with an Open‐Label Rescue Phase to Evaluate the Efficacy and Safety of Caffeine Citrate for Treatment of Apnea of Prematurity (AOP)

Next Previous
Trial Profile

A Multicenter, Parallel, Randomized, Double‐Blind, Placebo‐Controlled Trial with an Open‐Label Rescue Phase to Evaluate the Efficacy and Safety of Caffeine Citrate for Treatment of Apnea of Prematurity (AOP)

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 19 Apr 2018

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Caffeine citrate (Primary) ; Caffeine citrate (Primary)
  • Indications Apnoea
  • Focus Adverse reactions; Registrational; Therapeutic Use
  • Sponsors Roxane Laboratories

    • Most Recent Events

    • 19 Apr 2018 In this study (TGA document), 87 infants were randomized to two groups (46 were randomized to caffeine and 41 to placebo).Two patients did not receive drug and 3 were not included in the efficacy analysis because they had < 6 apnea episodes/24 hours at baseline.I have kept actual patient number as 87.
    • 19 Apr 2018 New trial record
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top